ScholarLens Back to search
2004•Journal watchRequires access

Using Abacavir + 3TC + Tenofovir for Treatment Simplification Might Court Virologic Failure

Abigail Zuger

Open publisher page 0 citations

Abstract

Studies have now repeatedly shown that for antiretroviral-naive patients, once-daily abacavir + 3TC + tenofovir results in unacceptably high rates of

About this research paper

What this paper is about

Studies have now repeatedly shown that for antiretroviral-naive patients, once-daily abacavir + 3TC + tenofovir results in unacceptably high rates of

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Studies have now repeatedly shown that for antiretroviral-naive patients, once-daily abacavir + 3TC + tenofovir results in unacceptably high rates of

Key concepts: Abacavir, Tenofovir, Medicine, Human immunodeficiency virus (HIV), Antiretroviral treatment, Antiretroviral therapy, Virology, Viral load

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Using Abacavir + 3TC + Tenofovir for Treatment Simplification Might Court Virologic Failure — Research Paper | ScholarLens